About this Journal Submit a Manuscript Table of Contents
Sarcoma
Volume 2013 (2013), Article ID 256280, 6 pages
http://dx.doi.org/10.1155/2013/256280
Clinical Study

Low-Grade Fibromyxoid Sarcoma: Incidence, Treatment Strategy of Metastases, and Clinical Significance of the FUS Gene

1Sarcoma Centre of Aarhus University Hospital, Denmark
2Department of Experimental Clinical Oncology, Aarhus University Hospital, Noerrebrogade 44, 8000 Aarhus C, Denmark
3Department of Pathology, Aarhus University Hospital, Noerrebrogade 44, 8000 Aarhus C, Denmark
4Department of Orthopaedic Surgery E5, Aarhus University Hospital, Noerrebrogade 44, 8000 Aarhus C, Denmark
5Department of Oncology, Aarhus University Hospital, Noerrebrogade 44, 8000 Aarhus C, Denmark

Received 25 February 2013; Accepted 13 May 2013

Academic Editor: R. Pollock

Copyright © 2013 Katja Maretty-Nielsen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Katja Maretty-Nielsen, Steen Baerentzen, Johnny Keller, Heidi Buvarp Dyrop, and Akmal Safwat, “Low-Grade Fibromyxoid Sarcoma: Incidence, Treatment Strategy of Metastases, and Clinical Significance of the FUS Gene,” Sarcoma, vol. 2013, Article ID 256280, 6 pages, 2013. doi:10.1155/2013/256280